Drug
Sorbitol
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | End Stage Renal Disease | 21 | 40.0 | 41.4 | signal |
| 2 | Blood Calcium Decreased | 9 | 28.0 | 28.4 | signal |
| 3 | Nephropathy | 6 | 22.4 | 22.6 | signal |
| 4 | Orthostatic Hypotension | 10 | 20.1 | 20.4 | signal |
| 5 | Squamous Cell Carcinoma | 5 | 18.6 | 18.8 | signal |
| 6 | Hemiparesis | 9 | 18.5 | 18.8 | signal |
| 7 | Meningioma | 7 | 16.7 | 16.9 | signal |
| 8 | Rotator Cuff Syndrome | 6 | 16.3 | 16.5 | signal |
| 9 | Intestinal Perforation | 5 | 15.6 | 15.7 | signal |
| 10 | Neuroleptic Malignant Syndrome | 5 | 14.7 | 14.9 | signal |
| 11 | Pneumocystis Jirovecii Pneumonia | 4 | 14.0 | 14.1 | signal |
| 12 | Fluid Overload | 5 | 11.9 | 12.0 | signal |
| 13 | Sedation | 8 | 10.8 | 10.9 | signal |
| 14 | Caesarean Section | 3 | 8.9 | 9.0 | signal |
| 15 | Anorexia | 3 | 8.0 | 8.1 | signal |
| 16 | Pancreatic Carcinoma | 4 | 4.8 | 4.9 | signal |